NuCana Plc (NCNA)
1.37
-0.01
(-0.72%)
USD |
NASDAQ |
Sep 02, 16:00
1.37
0.00 (0.00%)
After-Hours: 18:43
NuCana Cash from Operations (Annual) : -9.377M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -9.377M |
| December 31, 2024 | -23.95M |
| December 31, 2023 | -31.91M |
| December 31, 2022 | -27.74M |
| December 31, 2021 | -32.63M |
| December 31, 2020 | -27.31M |
| Date | Value |
|---|---|
| December 31, 2019 | -28.98M |
| December 31, 2018 | -15.00M |
| December 31, 2017 | -11.01M |
| December 31, 2016 | -11.92M |
| December 31, 2015 | -6.371M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Biodexa Pharmaceuticals Plc | -7.268M |
| Mereo BioPharma Group Plc | -31.04M |
| BioNTech SE | 514.63M |
| Silence Therapeutics Plc | -62.27M |
| Autolus Therapeutics Plc | -284.23M |